治疗性瘤疫苗的研究和临床进展
Chunyan Dong1, Zhuang Li1, Dejiang Tan1
1State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing 102629, China.
Vaccines
|July 30, 2025
概括
包括mRNA-4157在内的治疗癌症疫苗正在迅速发展. 这些创新的疫苗利用精确的抗原和高效的输送系统,在各种癌症的临床试验中显示出前景.
科学领域:
- 生物医学是生物医学.
- 疫苗学 疫苗学 疫苗学
- 在瘤学瘤学.
背景情况:
- 治疗性癌症疫苗是生物医学创新的重要领域,具有巨大的工业潜力.
- 新型疫苗标,载体,辅助剂和技术的开发正受到治疗癌症疫苗部门的推动.
- 许多大型制药和生物技术公司都积极参与推进治疗癌症疫苗项目的临床应用.
研究的目的:
- 系统地审查治疗癌症疫苗的当前研究和开发状态.
- 讨论各种治疗癌症疫苗模式的临床研究进展.
- 突出治疗癌症疫苗开发的新兴趋势,如精确抗原和组合疗法.
主要方法:
- 关于治疗癌症疫苗的现有文献的审查.
- 对不同类型疫苗 (病毒载体,细菌载体,细胞载体,质,核酸) 的临床研究数据的分析.
- 检查技术进步,包括脂质纳米颗粒 (LNP) 用于输送和个性化抗原策略.
主要成果:
- 各种治疗性癌症疫苗,包括病毒载体,细菌载体,细胞载体,质和核酸疫苗,正在临床研究中.
- 治疗性癌症疫苗正在趋向于精确的抗原,高效的载体 (如LNP),多种辅助剂和组合疗法.
- 结合个性化抗原和LNP的mRNA-4157疫苗显示了与黑色素瘤中免疫检查点抑制剂的协同效益.
结论:
- 治疗性癌症疫苗是一个快速发展的领域,具有强大的工业势头和临床翻译潜力.
- 技术进步使得癌症疫苗策略更加精确和有效.
- 结合方法,例如mRNA-4157与免疫疗法,显示出改善癌症治疗结果的重大前景.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.5K
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.4K
相关概念视频
01:30Cancer Vaccines
514
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
514
01:27Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K